Posted by Michael Wonder on 06 Feb 2018
AusBiotech says plan to disadvantage life sciences innovation
6 February 2018 - Response to Innovation and Science Australia 2030 plan.
Initial feedback from the life sciences sector finds the Innovation and Science Australia (ISA), 2030 strategic plan is another example of a plan skewed away from the needs of life sciences to short-horizon innovation.
ISA, Australia’s independent science, research and innovation advisory board, provides recommendations to the Federal Government as a “plan for Australia to thrive in the global innovation race”. The 125 page plan Australia 2030: Prosperity through Innovation articulates a view of the nation’s needs to ensure Australia’s world-class research can translate into social and economic prosperity.
